US High Growth Tech Stocks To Watch In June 2025
In the last week, the United States market has been flat, yet it has experienced a 13% increase over the past year with earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks involves looking for companies that not only align with these positive earnings expectations but also demonstrate innovation and adaptability in an evolving economic landscape.
Name
Revenue Growth
Earnings Growth
Growth Rating
Super Micro Computer
26.38%
39.09%
★★★★★★
Mereo BioPharma Group
53.63%
66.57%
★★★★★★
Ardelyx
20.78%
59.46%
★★★★★★
Travere Therapeutics
26.41%
64.47%
★★★★★★
TG Therapeutics
26.46%
38.75%
★★★★★★
AVITA Medical
27.28%
60.66%
★★★★★★
Alkami Technology
20.54%
76.67%
★★★★★★
Alnylam Pharmaceuticals
23.64%
61.12%
★★★★★★
Ascendis Pharma
35.15%
60.20%
★★★★★★
Lumentum Holdings
21.59%
110.32%
★★★★★★
Click here to see the full list of 228 stocks from our US High Growth Tech and AI Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Incyte Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics across the United States, Europe, Canada, and Japan with a market cap of $12.64 billion.
Operations: Incyte generates revenue primarily from its biotechnology segment, amounting to $4.41 billion. The company is involved in the discovery, development, and commercialization of therapeutics across multiple regions including the United States, Europe, Canada, and Japan.
Incyte's recent FDA approval of Zyny for squamous cell carcinoma and the settlement with Novartis highlight its strategic advances and potential cost reductions. Despite a challenging year with a 97.1% drop in earnings growth, projections are optimistic with an expected 20.94% annual earnings growth over the next three years. The company's commitment to R&D is evident from its significant investment, aligning with its focus on innovative cancer treatments and immune therapies that could redefine treatment paradigms in their respective fields.
Unlock comprehensive insights into our analysis of Incyte stock in this health report.
Learn about Incyte's historical performance.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: monday.com Ltd., along with its subsidiaries, develops software applications globally, including in the United States, Europe, the Middle East, Africa, and the United Kingdom; it has a market cap of approximately $15.44 billion.
Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $1.04 billion. Its operations span across multiple regions, offering software solutions internationally.
With a robust trajectory in both revenue and earnings, monday.com has demonstrated significant growth potential. In Q1 2025, the company's sales surged to $282.25 million from $216.91 million year-over-year, with net income escalating to $27.43 million from $7.08 million, reflecting a sharp increase in profitability and operational efficiency. This performance is underpinned by an aggressive R&D strategy that continually fuels innovation—evident from its recent forecast suggesting a 24% to 26% revenue growth for FY2025, aligning with its strategic market expansions and leadership enhancements such as the appointment of Casey George as CRO. These developments collectively underscore monday.com's adeptness at navigating the competitive tech landscape while maintaining strong growth momentum in software solutions.
Get an in-depth perspective on monday.com's performance by reading our health report here.
Gain insights into monday.com's past trends and performance with our Past report.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: TKO Group Holdings, Inc. is a sports and entertainment company with a market capitalization of approximately $31.58 billion.
Operations: TKO Group Holdings generates revenue primarily through its UFC and WWE segments, contributing approximately $1.45 billion and $1.47 billion respectively. The company operates in the sports and entertainment sector with a focus on these prominent brands.
TKO Group Holdings, Inc. has shown a notable uptick in its financial performance, with a recent revision in 2025's full-year revenue forecast to range between $3.005 billion and $3.075 billion, reflecting strong early-year results from its UFC and WWE segments. This adjustment represents an increase from earlier projections of $2.930 billion to $3.000 billion, underpinning the company's robust operational dynamics within the entertainment sector. Moreover, TKO's strategic partnerships and product launches, such as the new co-branded venture with Seagram's Escapes Spiked and WWE, demonstrate innovative market engagement strategies that enhance brand visibility and consumer reach across diverse demographics. The company also maintains shareholder value through consistent dividend payouts, with a recent declaration set at $0.38 per share for Class A stockholders—a testament to its commitment to returning capital to investors amidst expanding market operations.
Click here to discover the nuances of TKO Group Holdings with our detailed analytical health report.
Gain insights into TKO Group Holdings' historical performance by reviewing our past performance report.
Dive into all 228 of the US High Growth Tech and AI Stocks we have identified here.
Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:INCY NasdaqGS:MNDY and NYSE:TKO.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Super Micro Computer (SMCI) Teams Up with Ericsson to Power Edge AI with 5G Connectivity
Super Micro Computer, Inc. (NASDAQ:) is one of the 10 AI Stocks on Wall Street's Radar. On Tuesday, June 10th, Super Micro Computer, Inc. (NASDAQ:SMCI) and Ericsson (NASDAQ: ERIC) announced their intent to enter into a strategic collaboration that aims to accelerate Edge AI deployment. The two parties signed a Memorandum of Understanding to explore the integration of Ericsson Enterprise Wireless Solutions' industry-leading 5G connectivity with Supermicro's industry-leading Edge AI platforms, creating a commercial bundle that will deliver advanced Edge AI capabilities and simplify procurement and deployment. The need for such a collaboration rose out of demand for Edge AI solutions deploying pre-trained AI models, generative AI, and agentic AI to the network edge, outside the data center, for local processing. Since many of these AI applications require low-latency response times, combining Supermicro's and Ericsson's technology will help businesses deploy an integrated Edge AI infrastructure with wireless connectivity. Pixabay/Public Domain Some specific industry applications include retail, smart factory and industrial automation, traffic safety, and healthcare management. 'Supermicro delivers cutting-edge solutions that allow enterprises to harness the power of AI at the edge. Our compute platforms combined with Ericsson's 5G technology will allow enterprises and public sector organizations to extend the reach of their AI applications where wired technologies are not a viable option, such as smart intersections, industrial manufacturing, and remote infrastructure.' -Mory Lin, Vice President, IoT/Embedded & Edge Computing, Supermicro. While we acknowledge the potential of SMCI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
an hour ago
- Yahoo
Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions
Tandem Diabetes Care, Inc. recently announced a significant collaboration with Abbott Laboratories to integrate Abbott's upcoming dual glucose-ketone sensor with Tandem's insulin delivery systems. This and other collaborations, such as the agreement with Sequel Med Tech, align with Abbott's strategic focus on enhancing diabetes care. Abbott's shares rose 3% over the last quarter, aligning closely with broader market trends, which advanced 13% over the past year. The company's robust product approvals and partnerships, alongside positive market sentiment, likely reinforced investor confidence in Abbott's growth trajectory amid generally favorable market conditions. You should learn about the 1 possible red flag we've spotted with Abbott Laboratories. Find companies with promising cash flow potential yet trading below their fair value. The recent collaboration between Tandem Diabetes Care, Inc. and Abbott Laboratories to integrate Abbott's dual glucose-ketone sensor has the potential to enhance Abbott's market positioning in diabetes care. This partnership, along with other strategic agreements, could support revenue growth in Abbott's Diabetes Care segment, though challenges such as tariffs and VBP program impacts in China remain. Abbott's five-year total return, including share price and dividends, stands at 63.31%, showcasing strong longer-term performance, despite some earnings forecast pressure. In the past year, Abbott's shares have risen above the US Medical Equipment industry, which saw a return of 8.2%. This outperformance over a shorter time horizon indicates that investor confidence remains buoyant. However, the expectation of declining earnings over the next three years, with a 10.1% decrease per year, highlights forecast challenges. This contrasts with a forecasted revenue growth of 6.9% annually, which is slower than the broader US market growth rate of 8.6% per year. The current share price of US$133.06 reflects a modest 5.2% discount to the consensus analyst price target of US$140.41, suggesting a perception of fair valuation compared to expected earnings growth and projected revenue increases. Insights from our recent valuation report point to the potential undervaluation of Abbott Laboratories shares in the market. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:ABT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Vertiv Holdings Co (NYSE:VRT) Unveils AI-Ready Cooling Architecture For NVIDIA GB300 NVL72 Platform
Vertiv Holdings Co recently introduced an energy-efficient 142kW cooling and power reference architecture for the NVIDIA GB300 NVL72 platform, which aligns with broader trends driving technology innovation in data centers. Over the past quarter, Vertiv's stock price rose by 27%, a significant move partially supported by this product release. This rise contrasted with a more modest market uptick where indices like the S&P 500 and Nasdaq saw less dramatic increases, buoyed by benign inflation data and easing U.S.-China trade tensions. Vertiv's innovative strategies clearly supported its positive stock performance during this period. We've identified 2 possible red flags with Vertiv Holdings Co and understanding the impact should be part of your investment process. The latest GPUs need a type of rare earth metal called Neodymium and there are only 24 companies in the world exploring or producing it. Find the list for free. Vertiv Holdings Co's recent introduction of energy-efficient cooling and power solutions aligns well with its strategic focus on AI and data centers, potentially boosting future revenue and earnings. Over a remarkable three-year period, Vertiv's total shareholder return was very large at 1062.27%, reflecting favorable investor sentiment and strong business execution. Despite posting a compelling annual return, Vertiv shares underperformed the US Electrical industry, which saw a 24% increase over the past year. However, Vertiv has outpaced the broader US market, which returned 12.8% over the same period, underlining its robust performance. The collaboration with NVIDIA is likely to reinforce Vertiv's growth trajectory by catalyzing revenue growth through AI infrastructure projects. Analysts forecast a significant upward trend, with revenues expected to rise to approximately $12.2 billion by 2028. While the company's current share price is US$93.48, it remains below the consensus price target of US$108.14, indicating potential room for upside as the market adjusts to revised forecasts. Gain insights into Vertiv Holdings Co's future direction by reviewing our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:VRT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
